Skip to main content

Selective Detection of Brain Metastasis of Malignant Melanoma Using 18F-10B-L-Borono-Phenylalanine with Positron Emission Tomography

  • Chapter
Cancer Neutron Capture Therapy

Abstract

Selective neutron capture therapy (NCT) using specific dopa analog,10B-p-boronophenylalanine (10B-L-BPA) for malignant melanoma of the skin was developed and achieved many cures by Mishima and his group1,2. We had developed 18F-10B-L-Boronophenylalanine which can not only provide selective detection and three dimensional imaging, but also 10B concentration dynamics clinically using positron emission tomography (PET)3,4,5. The purpose of this study is to explore NCT of melanoma brain metastasis using this compound.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Y. Mishima, M. Ichihashi, S. Hatta, C. Honda, K. Yamamura and T. Nakagawa. New thermal neutron capture therapy for malignant melanoma; melanogenesis-seeking 10B molecule -melanoma cell interaction from in vivo to first clinical trial. Pig Cell Res 2: 226–234, 1989

    Article  CAS  Google Scholar 

  2. Y. Mishima, C. Honda, M. Ichihashi, H. Obara, H. Hiratsuka, H. Fukuda, H. Karashima, T. Kobayashi, K. Kanda and Y. Yoshino. Treatment of malignant melanoma by single neutron capture therapy with melanoma-seeking 1°B-Compound. Lancet II: 388–389, 1989

    Google Scholar 

  3. K. Ishiwata, T. Ido, K. Kawamura, K. Kubota, M. Ichihashi and Y. Mishima. 4-Borono-2-[18F] fluoroD-L-phenylalanine as a target compound for neutron capture therapy: tumor imaging potential with positron emission tomography. Nucl Med Biol 18: 745–751, 1991

    CAS  Google Scholar 

  4. K. Ishiwata, M. Shiono, K. Kubota, K. Yoshino, J. Hatazawa, T. Ido, C. Honda, M. Ichihashi, and Y. Mishima. A unique in vivo assessment of 4-[1°B]borono-L-phenylalanine in tumor tissue for boron neutron capture therapy of malignant melanoma using positron emission tomography and 4-borono-2[18F]fluoro-L-phenylalanine. Melanoma Res 2: 171–179, 1992.

    Article  PubMed  CAS  Google Scholar 

  5. Y. Mishima, Y. Imahori, C. Honda, S. Ueda, and T. Ido. In vitro diagnosis of human malignant melanoma using specific melanoma-seeking 18F-compound with positron emission tomography. Kyoto Univ Res Reactor Inst Tech Rep 374: 1–10, 1993

    Google Scholar 

  6. S. Somaza, D. Konzdiolka, L. D. Lunsford, J. M. Kirkwood and J. C. Flickinger. Stereotactic radiosurgery for cerebral metastatic melanoma, J Neurosurg 79: 661–666, 1993

    Article  PubMed  CAS  Google Scholar 

  7. R. G. Bristow, P. A. Hardy, and R. P. Hill. Comparison between in vitro radiosensitivity and in vivo radioresponse of murine cell lines: 1, Parameters of in vitro radiosensitivity and endogenous cellular glutathione levels. Int J Radiat Oncol Biol Phys 18: 133–145, 1990

    Article  PubMed  CAS  Google Scholar 

  8. B. Larsson. Radiobiological fundamentals in radiosurgery. In Radiosurgery: baseline and trends: ed. L. Steiner et al., Raven Press, New York 3–14, 1992

    Google Scholar 

  9. K. Matalka, M. Q. Bailey, R. F. Barth, A. E. Staubus, A.H. Soloway, M.L. Moeschberger, J. A. Codere and E. K. Rofstad. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent. Cancer Res 53: 3308–3313, 1993

    PubMed  CAS  Google Scholar 

  10. R. F. Barth, K. Z. Matalka, M. Q. Bailey, A. E. Staubus, A. H. Soloway, M. L. Moeschberger, J. A. Codere and E. K. Rofstad. A nude rat model for neutron capture therapy of human intracerebral melanoma. Int J Radiat Oncol Biol Phys 28: 1079–1088, 1994.

    Article  PubMed  CAS  Google Scholar 

  11. J. L. Mallesch, B. P. Hons, D. E. Moore, B. J. Allen, W. H. McCarthy, R. J.Jones, and W. A. Stening. The pharmacokinetics of p-boronophenylalanine-fructose in human patients with glioma and metastatic melanoma. Int J Radiat Oncol Biol Phys 28: 1183–1188, 1994

    Article  PubMed  CAS  Google Scholar 

  12. R. V. Dorn. Boron neutron capture therapy (BNCT): a radiation oncology perspective. Int J Radiat Oncol Biol Phys 28, 1189–1201, 1994

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ehara, K. et al. (1996). Selective Detection of Brain Metastasis of Malignant Melanoma Using 18F-10B-L-Borono-Phenylalanine with Positron Emission Tomography. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_117

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9567-7_117

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9569-1

  • Online ISBN: 978-1-4757-9567-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics